AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

CGM technology could become a cornerstone in modern diabetes management. Credit: Halfpoint via Shutterstock. In a groundbreaking application of data science, researchers have revisited the landmark ...

Relmada has acquired complete ownership rights to Sepranolone, developed for Tourette syndrome (TS) from Asarina Pharma.

Alumis and Acelyrin have announced a definitive merger agreement, which will result in an all-stock transaction.

In a statement released on World Cancer Day (4 February), WHO’s Southeast Asia regional director Saima Wazed stated that the ...

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.

Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.